Search results
Adam Bass, MD, joined Columbia University Irving Medical Center in January of 2021 from Dana-Farber/Harvard Cancer Center. A leading physician-scientist in genomics and gastrointestinal cancer, Dr. Bass’ research aims to translate findings uncovered in the lab into better and more effective therapeutics for patients with cancer.
Oct 29, 2020 · Adam Bass, MD, will join the Herbert Irving Comprehensive Cancer Center as founding director of the Center for Precision Cancer Medicine and director of gastrointestinal oncology.
Join our MD program to become a physician with compassion, a sense of self, and true grit in all medical pursuits. Explore Our Program
Adam Mor, MD, PhD, is the Herbert Irving Associate Professor of Medicine in the Division of Rheumatology at Columbia University’s Vagelos College of Physicians and Surgeons. He heads the Mor Lab, located in the Columbia Center for Translational Immunology at Columbia University Irving Medical Center.
Adam Bass, MD is a physician-scientist who has studied the genomic underpinning of gastric and esophageal cancer and subsequently performed functional genomic studies to define the biological bases and molecular vulnerabilities in these cancers.
Nov 25, 2020 · Adam Bass, MD, a physician-scientist in the field of cancer genomics and gastrointestinal cancer, will join the Herbert Irving Comprehensive Cancer Center at Columbia University and NewYork-Presbyterian as the founding Director of the Center for Precision Cancer Medicine and Director of Gastrointestinal Oncology.
Dec 21, 2017 · A research collaboration underway between Columbia’s Department of Systems Biology, the Broad Institute of MIT and Harvard, and Columbia University Medical Center (CUMC) is working to accelerate the discovery of new cancer drug combinations targeted at gastric and esophageal cancer.
